We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 47.33%
This Fund
S&P 500
This Quarter Est. Return
+15.81%
1 Year Est. Return
+47.33%
3 Year Est. Return
+126.67%
5 Year Est. Return
+163.42%
10 Year Est. Return
+1,200.89%
AUM
$1.9M
AUM Growth
-$433M
Cap. Flow
-$13.7M
Cap. Flow %
-721.78%
Top 10 Hldgs %
80.77%
Holding
182
New
10
Increased
41
Reduced
77
Closed
6

Top Buys

Rank Stock Value
1
VYX icon
NCR Voyix
VYX
+$2.42M
2
BHP icon
BHP
BHP
+$1.84M
3
O icon
Realty Income
O
+$775K
4
ORCL icon
Oracle
ORCL
+$729K
5
EBAY icon
eBay
EBAY
+$721K

Sector Composition

Rank Sector Weight
1 Healthcare 48.23%
2 Financials 33.49%
3 Technology 4.23%
4 Industrials 2.84%
5 Consumer Staples 2.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$219B
$5.88K 0.31%
51,560
-2,150
-4% -$245K
MOS icon
27
The Mosaic Company
MOS
$7.46B
$5.79K 0.3%
122,525
+8,500
+7% +$394K
MDT icon
28
Medtronic
MDT
$110B
$5.69K 0.3%
99,215
-3,899
-4% -$221K
AGCO icon
29
AGCO
AGCO
$7.12B
$5.67K 0.3%
95,803
+1,900
+2% +$113K
MSFT icon
30
Microsoft
MSFT
$3.71T
$5.56K 0.29%
148,700
-3,500
-2% -$127K
PG icon
31
Procter & Gamble
PG
$342B
$5.54K 0.29%
68,056
-1,400
-2% -$114K
EBAY icon
32
eBay
EBAY
$48.9B
$5.54K 0.29%
239,857
+32,551
+16% +$721K
SYK icon
33
Stryker
SYK
$129B
$5.52K 0.29%
73,500
+1,650
+2% +$120K
ABBV icon
34
AbbVie
ABBV
$431B
$5.4K 0.28%
102,255
-3,700
-3% -$182K
EPD icon
35
Enterprise Products Partners
EPD
$82.3B
$5.36K 0.28%
161,750
-5,400
-3% -$168K
LUMN icon
36
Lumen
LUMN
$6.09B
$5.32K 0.28%
167,125
-7,700
-4% -$246K
HUN icon
37
Huntsman Corp
HUN
$1.78B
$5.17K 0.27%
210,000
DIS icon
38
Walt Disney
DIS
$182B
$5.16K 0.27%
67,592
-5,500
-8% -$381K
WFC icon
39
Wells Fargo
WFC
$265B
$5.08K 0.27%
111,926
-5,200
-4% -$225K
LOW icon
40
Lowe's Companies
LOW
$122B
$5.04K 0.27%
101,781
-5,000
-5% -$243K
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$4.85K 0.26%
26,280
+40
+0.2% +$7.08K
WMT icon
42
Walmart Inc
WMT
$892B
$4.15K 0.22%
158,127
-6,750
-4% -$174K
SLB icon
43
SLB Ltd
SLB
$76.5B
$3.81K 0.2%
42,300
+200
+0.5% +$18.1K
JNJ icon
44
Johnson & Johnson
JNJ
$619B
$3.79K 0.2%
41,394
+652
+2% +$60.1K
ABT icon
45
Abbott
ABT
$187B
$3.75K 0.2%
97,955
-2,300
-2% -$84.8K
CVS icon
46
CVS Health
CVS
$123B
$3.73K 0.2%
52,149
-2,875
-5% -$185K
DD icon
47
DuPont de Nemours
DD
$19.5B
$3.71K 0.2%
33,022
+395
+1% +$40.5K
JCI icon
48
Johnson Controls International
JCI
$93.6B
$3.7K 0.19%
68,879
-4,537
-6% -$223K
PPLI
49
People Inc
PPLI
$3.2B
$3.7K 0.19%
301,509
-22,493
-7% -$232K
PFE icon
50
Pfizer
PFE
$149B
$3.65K 0.19%
125,722
-6,693
-5% -$195K

Similar funds

Marco Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Marco Investment Management held 182 positions worth $1.9M, down 100% from $435M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Marco Investment Management withdrew a net $13.7M in Q4 2013, closing 6 positions and reducing 77 holdings. Its most notable exit was Endo International plc, an estimated $2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marco Investment Management opened a new position in Realty Income worth $730.

  • Marco Investment Management's largest Q4 2013 buy was Realty Income: 20,176 shares worth $730.
  • Marco Investment Management added most to NCR Voyix in Q4 2013, an estimated $2.42M increase.
  • Marco Investment Management's biggest Q4 2013 reduction was Cognizant, cutting an estimated $3.47M.
  • Marco Investment Management fully exited Endo International plc in Q4 2013, selling an estimated $2M.
  • Marco Investment Management's ten largest holdings make up 81% of its $1.9M portfolio in Q4 2013.
  • Marco Investment Management opened 10 new positions and closed 6 in Q4 2013.
  • Marco Investment Management's portfolio value fell 100% quarter-over-quarter to $1.9M.

Based on Marco Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.